Skip to Content
Home > Conditions & Services > Cancer > Clinical Trials Search Results
Cardiovascular Safety of Exenatide Once Weekly (Type 2 Diabetes)
Effects of four classes of drugs in combination with metformin for the treatment of type 2 diabetes.
Iron reduction by blood donation for the prevention and treatment of type 2 diabetes
PF-04634817 is a chemokine CCR2/5 receptor antagonist that is being developed for the treatment of diabetic nephropathy
©2013 University of Colorado Hospital.